The Leipzig TAVI Registry

NCT05015452 · tracked via the Priya Life Science Germany tracker

Sponsor

Helios Health Institute GmbH

Phase

Observational

Started

2020-03-01

Last updated

2024-10-09

Condition(s) studied

Aortic Valve Stenosis

Investigational drug(s) / intervention(s)

Transcatheter Aortic Valve Implantation

Transcatheter Aortic Valve Implantation: Interventional replacement of the aortic valve

Study summary

A single-center registry including all patients treated with TAVI at the Heart Center, Leipzig, Germany

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * All patients treated with TAVI Exclusion Criteria: * None

Primary outcome measure(s)

Mortality — Up to 10 years
Cardiovascular and not cardiovascular death 1. identify the current incidence of periprocedural complications. 2. identification of risk groups 3. description of the long-term outcome with special attention to the durability of the different prostheses

Trial sites (1)

Facility	City	Region	Status
Herzzentrum Leipzig	Leipzig	Germany	Recruiting

More Helios Health Institute GmbH trials in Germany

The Helios Heart Registry: A Standardized Registry for Patients With Specific Cardiac Diseases Recruiting

Comparison of Vessel-FFR Versus FFR in Intermediate Coronary Stenoses Recruiting

Remote Ischemic Conditioning With Local Ischemic Postconditioning in High-Risk ST-elevation Myocardial Infarction Active, not recruiting

Complete Functional Assessment of Intermediate Coronary Artery Stenosis Before and After Transcatheter Aortic Valve Implantation (TAVI) in Patients With Severe Symptomatic Aortic Valve Stenosis Recruiting

Other trials for the same condition

accuRate Evaluation of Benefit With Optimal Medical Treatment With or Without Transcatheter Valve Repair of PARADOXical Low Flow Low Gradient Aortic Stenosis Active, not recruiting

Correlation of FFR and iFR With Cardiac PET Perfusion in Patients With Severe Aortic Valve Stenosis Recruiting

Effect of Fetal Aortic Valvuloplasty on Outcomes Recruiting

The Prospective Segeberg TAVI Registry Recruiting

Randomized Trial of TAVI vs. SAVR in Patients With Severe Aortic Valve Stenosis at Low to Intermediate Risk of Mortality Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05015452 on ClinicalTrials.gov ↗ ← All trials in Germany